Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adultsenglish
Version: 2 ID: 11-2 Oct 2014
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
Adult patients with resected soft tissue sarcoma.
- What are the benefits of anthracycline-based adjuvant chemotherapy in adult patients with completely resected soft tissue sarcomas, in terms of local disease control, systemic recurrence, and overall survival?
- When these benefits are assessed in the context of expected toxicities, in what circumstances should adjuvant chemotherapy be recommended?
- Are there any advantages in using combination versus single-agent anthracycline-based chemotherapy in the adjuvant setting?
Full Report (PDF) (907.05 KB)